Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 347

1.

Diagnostic sensitivity of culture and drug resistance patterns in Korean patients with intestinal tuberculosis.

Ye BD, Yang SK, Kim D, Shim TS, Kim SH, Kim MN, Lee YJ, Na HK, Park SH, Yang DH, Kim KJ, Byeon JS, Myung SJ, Kim JH.

Int J Tuberc Lung Dis. 2012 Jun;16(6):799-804. doi: 10.5588/ijtld.11.0252. Epub 2012 Apr 9.

PMID:
22508109
2.

First- and second-line anti-tuberculosis drug resistance in Northwest Ethiopia.

Tessema B, Beer J, Emmrich F, Sack U, Rodloff AC.

Int J Tuberc Lung Dis. 2012 Jun;16(6):805-11. doi: 10.5588/ijtld.11.0522. Epub 2012 Feb 29.

PMID:
22390880
3.

Performance of culture and drug susceptibility testing in pulmonary tuberculosis patients in northern China.

Qi W, Harries AD, Hinderaker SG.

Int J Tuberc Lung Dis. 2011 Jan;15(1):137-9.

PMID:
21276311
4.

Implementation of the INNO-LiPA Rif. TB® line-probe assay in rapid detection of multidrug-resistant tuberculosis in Latvia.

Skenders GK, Holtz TH, Riekstina V, Leimane V.

Int J Tuberc Lung Dis. 2011 Nov;15(11):1546-52, i. doi: 10.5588/ijtld.11.0067.

PMID:
22008771
5.

Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.

Kim HR, Hwang SS, Kim HJ, Lee SM, Yoo CG, Kim YW, Han SK, Shim YS, Yim JJ.

Clin Infect Dis. 2007 Nov 15;45(10):1290-5. Epub 2007 Oct 15.

PMID:
17968823
6.

Recurrence after successful treatment among patients with multidrug-resistant tuberculosis.

Lee J, Lim HJ, Cho YJ, Park YS, Lee SM, Yang SC, Yoo CG, Kim YW, Han SK, Yim JJ.

Int J Tuberc Lung Dis. 2011 Oct;15(10):1331-3. doi: 10.5588/ijtld.11.0098.

PMID:
22283890
7.

Treatment outcomes for HIV-uninfected patients with multidrug-resistant and extensively drug-resistant tuberculosis.

Kwon YS, Kim YH, Suh GY, Chung MP, Kim H, Kwon OJ, Choi YS, Kim K, Kim J, Shim YM, Koh WJ.

Clin Infect Dis. 2008 Aug 15;47(4):496-502. doi: 10.1086/590005.

PMID:
18611154
8.

First-line anti-tuberculosis drug resistance patterns and trends at the national TB referral center in Iran--eight years of surveillance.

Shamaei M, Marjani M, Chitsaz E, Kazempour M, Esmaeili M, Farnia P, Tabarsi P, Amiri MV, Mirsaeidi M, Mansouri D, Masjedi MR, Velayati AA.

Int J Infect Dis. 2009 Sep;13(5):e236-40. doi: 10.1016/j.ijid.2008.11.027. Epub 2009 Mar 13.

9.

Converging risk factors but no association between HIV infection and multidrug-resistant tuberculosis in Kazakhstan.

van den Hof S, Tursynbayeva A, Abildaev T, Adenov M, Pak S, Bekembayeva G, Ismailov S.

Int J Tuberc Lung Dis. 2013 Apr;17(4):526-31. doi: 10.5588/ijtld.12.0703.

PMID:
23485387
10.

Representative drug susceptibility patterns for guiding design of re-treatment regimens for multidrug-resistant tuberculosis in Iran.

Tabarsi P, Nooraki A, Mirsaeidi M, Amiri M, Baghaei P, Farnia P, Kazempour M, Heidarnazhad H, Alipanah N, Mansouri D, Masjedi MR.

Respirology. 2008 Jan;13(1):108-11. doi: 10.1111/j.1440-1843.2007.01201.x.

PMID:
18197919
11.

Nature of drug resistance and predictors of multidrug-resistant tuberculosis among patients seen at the Philippine General Hospital, Manila, Philippines.

Mendoza MT, Gonzaga AJ, Roa C, Velmonte MA, Jorge M, Montoya JC, Tan Torres T, Ong M, Barez MY, Ang CF.

Int J Tuberc Lung Dis. 1997 Feb;1(1):59-63.

PMID:
9441060
12.

Anti-tuberculosis drug resistance and associated risk factors in a tertiary level TB center in Iran: a retrospective analysis.

Merza MA, Farnia P, Tabarsi P, Khazampour M, Masjedi MR, Velayati AA.

J Infect Dev Ctries. 2011 Jul 27;5(7):511-9.

13.

Increase in anti-tuberculosis drug resistance in Botswana: results from the fourth National Drug Resistance Survey.

Menzies HJ, Moalosi G, Anisimova V, Gammino V, Sentle C, Bachhuber MA, Bile E, Radisowa K, Kachuwaire O, Basotli J, Maribe T, Makombe R, Shepherd J, Kim B, Samandari T, El-Halabi S, Chirenda J, Cain KP.

Int J Tuberc Lung Dis. 2014 Sep;18(9):1026-33. doi: 10.5588/ijtld.13.0749.

PMID:
25189548
14.

[Frequency of drug resistant tuberculosis in Poland in 2000 as compared to 1997].

Augustynowicz-Kopeć E, Zwolska Z, Jaworski A, Kostrzewa E, Klatt M, Swiderska A, Drozd I.

Pneumonol Alergol Pol. 2002;70(3-4):193-202. Polish.

PMID:
12271966
15.

Retrospective comparison of levofloxacin and moxifloxacin on multidrug-resistant tuberculosis treatment outcomes.

Lee J, Lee CH, Kim DK, Yoon HI, Kim JY, Lee SM, Yang SC, Lee JH, Yoo CG, Lee CT, Chung HS, Kim YW, Han SK, Yim JJ.

Korean J Intern Med. 2011 Jun;26(2):153-9. doi: 10.3904/kjim.2011.26.2.153. Epub 2011 Jun 1.

16.

Multi-drug-resistant tuberculosis: the experience of an urban tertiary care hospital in South India using automated BACTEC 460 TB.

Mishra B, Rockey SM, Gupta S, Srinivasa H, Muralidharan S.

Trop Doct. 2012 Jan;42(1):35-7. doi: 10.1258/td.2011.110247. Epub 2011 Nov 11.

PMID:
22080484
17.

Survey of tuberculosis drug resistance among Tibetan refugees in India.

Salvo F, Dorjee K, Dierberg K, Cronin W, Sadutshang TD, Migliori GB, Rodrigues C, Trentini F, Di Serio C, Chaisson R, Cirillo DM.

Int J Tuberc Lung Dis. 2014 Jun;18(6):655-62. doi: 10.5588/ijtld.13.0516.

PMID:
24903934
18.

Mycobacterium tuberculosis drug-resistance in previously treated patients in Ouagadougou, Burkina Faso.

Sangare L, Diande S, Kouanda S, Dingtoumda BI, Mourfou A, Ouedraogo F, Sawadogo I, Nebie B, Gueye A, Sawadogo LT, Traore AS.

Ann Afr Med. 2010 Jan-Mar;9(1):15-9. doi: 10.4103/1596-3519.62619.

19.

Genetic diversity of Mycobacterium tuberculosis in Madang, Papua New Guinea.

Ballif M, Harino P, Ley S, Carter R, Coulter C, Niemann S, Borrell S, Fenner L, Siba P, Phuanukoonnon S, Gagneux S, Beck HP.

Int J Tuberc Lung Dis. 2012 Aug;16(8):1100-7. doi: 10.5588/ijtld.11.0779. Epub 2012 Jun 14.

PMID:
22710686
20.

GenoType® MTBDRplus assay detection of drug-resistant tuberculosis in routine practice in Korea.

Lyu J, Kim MN, Song JW, Choi CM, Oh YM, Lee SD, Kim WS, Kim DS, Shim TS.

Int J Tuberc Lung Dis. 2013 Jan;17(1):120-4. doi: 10.5588/ijtld.12.0197.

PMID:
23232012

Supplemental Content

Support Center